Latest News
The first human trial testing a potential COVID-19 vaccine has been successful, with initial results suggesting the vaccine is safe and capable of generating an immune response against SARS-CoV-2 in humans.
Researchers have demonstrated that two COVID-19 vaccine candidates can protect against COVID-19 in primates, with re-exposure triggering an immune response in rhesus macaques.
After analyzing data from SARS survivors, a team of researchers from across the globe has identified an antibody that can inhibit related coronaviruses, including SARS-CoV-2. The antibody, termed S309, is now on an accelerated path towards clinical trials.
Journal Articles
Take a look behind the scenes of a recent Future Virology editorial entitled, ‘An insight into dengue virus proteins as potential drug/vaccine targets’, as we ask author Muhammad Faheem about recent advances in understanding dengue proteins and where the next 5–10 years could take us.
Take a look behind the scenes of a recent Future Virology article, entitled ‘Update on HIV integrase inhibitors for the treatment of HIV’, as we ask the authors about these drugs for HIV treatment and the future of this field.
Take a look behind the scenes of a recent Future Microbiology article, entitled ‘New insights of CRISPR technology in pathogenic fungi’, as we ask author Elvira Román (Complutense University of Madrid, Spain) about the advances CRISPR technology has already brought to this field and the potential it could hold in the future.
Bacterial
The role of humoral immunity in TB defense – an interview with Babak Javid
Competence-inhibiting drugs may prevent the spread of antibiotic resistance
The race for COVID-19 treatments and vaccines: February’s industry headlines
Clostridium Difficile Infection
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
IDWeek: Antibiotics before dental visits are overprescribed and increase the risk of side effects
Transkingdom interactions: elevated levels of fungi observed in Clostridium difficile infection
E. Coli
Antibodies from maternal microbiota could protect newborns from infection
Multidrug efflux systems: information on evolution and mechanisms uncovered
E. coli created with world’s first synthetic and redesigned genome
H. Pylori
Organoids: a new model to study infectious diseases?
MRSA
The race for COVID-19 treatments and vaccines: February’s industry headlines
New study reveals how the household environment influences MRSA spread
Novel vaccine candidate for Staphylococcus aureus shows 80% efficacy in mice
Salmonella
Novel models for enteric infections – an interview with the Faherty Lab
Tuberculosis
The role of humoral immunity in TB defense – an interview with Babak Javid
Changing the administration of the BCG vaccine could improve efficacy
WHO prequalifies Ebola vaccine: November’s industry headlines
Fungal
A peek behind the paper – Elvira Román on CRISPR technology in pathogenic fungi
The best of 2019 – an A–Z of infectious diseases research
A peek behind the paper – Shujuan Sun on using existing antibiotics as antifungals
Aspergillosis
Fungal biofilm morphology impacts disease progression
#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week
Novel antifungal presents opportunities for treating aspergillosis
Candidiasis
A peek behind the paper – Elvira Román on CRISPR technology in pathogenic fungi
A peek behind the paper – Shujuan Sun on using existing antibiotics as antifungals
Could climate change have contributed to Candida auris emergence?
Coccidioidomycosis
#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week
Identification of membrane proteome of Paracoccidioides lutzii and its regulation by zinc
Cryptococcal Meningitis
#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week
Parasitic
Malaria: triple artemisinin-based combination therapies safe and effective
Is coffee consumption contributing to malaria transmission?
Novel parasites and understanding parasite–host interactions – an interview with Sandra Maruyama
Helminthic Infections
Conference report – London Centre for Neglected Tropical Disease Research Anniversary Event
ISNTD – Female Genital Schistosomiasis: The most neglected gynaecological disease
Conference report – British Society for Parasitology Autumn Symposium
Malaria
Malaria: triple artemisinin-based combination therapies safe and effective
Is coffee consumption contributing to malaria transmission?
World Malaria Report 2019: a focus on pregnant women and children
Neglected Tropical Diseases
Novel parasites and understanding parasite–host interactions – an interview with Sandra Maruyama
Mice, introduced by maritime trade, play a key role in Toxoplasma gondii distribution
Protozoan Infections
Malaria: triple artemisinin-based combination therapies safe and effective
World Malaria Report 2019: a focus on pregnant women and children
Imaging study reveals how malaria parasites bypass antimalarial drugs
Viral
First human COVID-19 vaccine trial displays promising results
Primate studies offer hope for future COVID-19 vaccine development
Neutralizing SARS antibody also blocks related coronaviruses
Hepatitis
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines
Herpes
ASM Microbe: What consequences could lifelong Epstein–Barr virus infection have for the brain?
HR-HPV oral infection rates in England are lower than expected
A peek behind the paper – Lynn Enquist on the lifecycle of alpha herpesvirus
